APGE

Apogee Therapeutics, Inc.

Contracts

Total Value

Stock Metrics

7.3%

Short % Float

4.0d to cover · Moderate squeeze

1.1%

Inst % Float

10 holders · 2026-06-30

T. Rowe Price Inve

Top Holder

16.6% of float

57.8M sh

Public Float

39/100

Dilution Score

Medium

87 mo

Cash Runway

Verified regulatory filings & proprietary analysis.

Dilution Risk

39/100

MEDIUM

Inst: 1.1% · Top: T. Rowe Price Investment Management, Inc.

Biotech Analytics

Immunology

24.96

Squeeze risk: MODERATEBiotech Grade: F

Insider Buying0

Publications100

Dilution Risk39

Clinical Trials33

Short Interest30